Radiofrequency ablation for the treatment of recurrent bone and soft-tissue sarcomas in non-surgical candidates

[1] Grimer R(2010)Guidelines for the management of soft-tissue sarcomas Sarcoma 2010 506182-2221

[2] Judson I(2005)Treatment of osteosarcoma at first recurrence after contemporary therapy: The Memorial Sloan-Kettering Cancer Center experience Cancer 104 2214-755

[3] Peake D(2005)Treatment and outcome of recurrent osteosarcoma: experience at Rizzoli in 235 patients initially treated with neoadjuvant chemotherapy Acta Oncol 44 748-715

[4] Chou AJ(2003)Postrelapse survival in osteosarcoma of the extremities: prognostic factors for long-term survival J Clin Oncol 21 710-vii99

[5] Merola PR(2012)Soft-tissue and visceral sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Ann Oncol Suppl 7 vii92-vii109

[6] Wexler LH(2012)Bone sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Ann Oncol Suppl 7 vii100-28

[7] Bacci G(2002)Treatment and outcome of recurrent pelvic chondrosarcoma Clin Orthop Relat Res 397 19-3781

[8] Briccoli A(2009)Lung radiofrequency ablation in patients with pulmonary metastases from musculoskeletal sarcomas Cancer 115 3774-1285

[9] Longhi A(1993)An intergroup phase III randomized study of doxorubicin and dacarbazine with or without ifosfamide and mesna in advanced soft-tissue and bone sarcomas J Clin Oncol 11 1276-S216

[10] Ferrari S(2008)Percutaneous radiofrequency ablation for treatment of recurrent retroperitoneal liposarcoma Cardiovasc Intervent Radiol 31 S213-223

[1] Grimer R(2010)Guidelines for the management of soft-tissue sarcomas Sarcoma 2010 506182-2221

[2] Judson I(2005)Treatment of osteosarcoma at first recurrence after contemporary therapy: The Memorial Sloan-Kettering Cancer Center experience Cancer 104 2214-755

[3] Peake D(2005)Treatment and outcome of recurrent osteosarcoma: experience at Rizzoli in 235 patients initially treated with neoadjuvant chemotherapy Acta Oncol 44 748-715

[4] Chou AJ(2003)Postrelapse survival in osteosarcoma of the extremities: prognostic factors for long-term survival J Clin Oncol 21 710-vii99

[5] Merola PR(2012)Soft-tissue and visceral sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Ann Oncol Suppl 7 vii92-vii109

[6] Wexler LH(2012)Bone sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Ann Oncol Suppl 7 vii100-28

[7] Bacci G(2002)Treatment and outcome of recurrent pelvic chondrosarcoma Clin Orthop Relat Res 397 19-3781

[8] Briccoli A(2009)Lung radiofrequency ablation in patients with pulmonary metastases from musculoskeletal sarcomas Cancer 115 3774-1285

[9] Longhi A(1993)An intergroup phase III randomized study of doxorubicin and dacarbazine with or without ifosfamide and mesna in advanced soft-tissue and bone sarcomas J Clin Oncol 11 1276-S216

[10] Ferrari S(2008)Percutaneous radiofrequency ablation for treatment of recurrent retroperitoneal liposarcoma Cardiovasc Intervent Radiol 31 S213-223